510(k) Report

510(k) · Cleared

Cleared

Terumo U-100 Insulin Syring

K001474510(k) SpecialCleared Jun 9, 200029-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Terumo Medical Corp. · FMF Syringe, Piston

Cleared on Jun 9, 2000 after a 29-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 83 later devices descend from it.

Decided
Jun 9, 2000
Review
29 days
Class
Class II
Product code
FMF
Recalls
None
Predicates
0

83 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2017: 5 descendants cleared2008: 1 descendant cleared2009: 1 descendant cleared2016: 3 descendants cleared2011: 4 descendants cleared2018: 3 descendants cleared2015: 1 descendant cleared2021: 13 descendants cleared2013: 1 descendant cleared2012: 1 descendant cleared2023: 15 descendants cleared2019: 2 descendants cleared2022: 13 descendants cleared2020: 4 descendants cleared2024: 6 descendants cleared2025: 6 descendants cleared2026: 3 descendants cleared200020052010201520202025
  1. This deviceK001474 Terumo U-100 Insulin SyringTerumo Medical Corp. · 2000
  2. Descendant · cites it directly · 82 of its ownK071630 Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp. · 2007
  3. Descendant · 2 generations on · 78 of its ownK072739 Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008
  4. Descendant · 3 generations on · 36 of its ownK110421 Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011
  5. Descendant · 3 generations on · 31 of its ownK112057 KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011
  6. Descendant · 4 generations on · 13 of its ownK190002 Sterile Hypodermic Syringe for Single use, with/without needle…Shanghai Kohope Medical Devices Co., Ltd. · 2019

Showing 5 of 83 descendants. See all descendants

Descendants cleared per year

2007: 12008: 12009: 12011: 42012: 12013: 12015: 12016: 32017: 52018: 32019: 22020: 42021: 132022: 132023: 152024: 62025: 62026: 3
2007high 15 (2023) · low 0 (2010)2026

Most influential descendants

Showing 5 of 83 · See all
  • K071630Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp. · 2007 · cites it directly82descendants
  • K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008 · 2 generations on78descendants
  • K110421Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011 · 3 generations on36descendants
  • K112057KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011 · 3 generations on31descendants
  • K190002Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Insulin Syringe…Shanghai Kohope Medical Devices Co., Ltd. · 2019 · 4 generations on13descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K001474Terumo U-100 Insulin SyringTerumo Medical Corp.2000—
+1K071630Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp.2007—
+2K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd.2008—
+3K110421Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd.2011—
+3K112057KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co.,2011—
+4K190002Sterile Hypodermic Syringe for Single use, with/without needle, Sterile…Shanghai Kohope Medical Devices Co., Ltd.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
200910
201140
201210
201310
201510
201630
201750
201830
201920
202040
2021130
2022130
2023150
202460
202560
202630
FIG. 1 — Lineage of K001474, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

  1. #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (83)

See all 83

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071630Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp.200782

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K071630 (Terumo Medical Corp., 2007) has gone furthest, with 82 descendants of its own.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FMF

13in 2025

2007: 232008: 92009: 142010: 112011: 162012: 92013: 122014: 132015: 112016: 122017: 132018: 82019: 112020: 152021: 202022: 242023: 222024: 142025: 132026 (partial year): 9
2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007: 90 days median2008: 74 days median2009: 94 days median2010: 130 days median2011: 109 days median2012: 86 days median2013: 154 days median2014: 84 days median2015: 87 days median2016: 146 days median2017: 135 days median2018: 87 days median2019: 146 days median2020: 107 days median2021: 175 days median2022: 211 days median2023: 173 days median2024: 130 days median2025: 114 days median2026 (partial year): 239 days median
2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007: 62008: 112009: 152010: 122011: 32012: 62013: 12014: 12015: 22017: 32018: 22019: 12020: 22021: 12022: 22023: 19, 18 Class I2026 (partial year): 2, 1 Class I
2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007: 6742008: 6912009: 9132010: 6792011: 1862012: 3072013: 3262014: 2442015: 2732016: 6842017: 1,8582018: 3,9522019: 5,8632020: 5,3342021: 5,8742022: 5,2332023: 5,2142024: 5,1222025: 4,181
2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200723906674
200897411691
2009149415913
20101113012679
2011161093186
20129866307
2013121541326
201413841244
201511872273
2016121460684
20171313531,858
201888723,952
20191114615,863
20201510725,334
20212017515,874
20222421125,233
20232217319 (18)5,214
20241413005,122
20251311404,181
202692392 (1)—
Cite this page

510(k) Report. “K001474: Terumo U-100 Insulin Syring.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K001474

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026